Literature DB >> 12540053

Pin1: a therapeutic target in Alzheimer neurodegeneration.

Malika Hamdane1, Caroline Smet, Anne-Véronique Sambo, Arnaud Leroy, Jean-Michel Wieruszeski, Patrice Delobel, Claude-Alain Maurage, Antoine Ghestem, René Wintjens, Séverine Bégard, Nicolas Sergeant, André Delacourte, Dragos Horvath, Isabelle Landrieu, Guy Lippens, Luc Buée.   

Abstract

In Alzheimer's disease, the peptidyl prolyl cis/trans isomerase Pin1 binds to phospho-Thr231 on Tau proteins and, hence, is found within degenerating neurons, where it is associated to the large amounts of abnormally phosphorylated Tau proteins. Conversely, Pin1 may restore the tubulin polymerization function of these hyperphosphorylated Tau. In the present work, we investigated, both at the cellular and molecular levels, the role of Pin1 in Alzheimer's disease through the study of its interactions with phosphorylated Tau proteins. We also showed that in neuronal cells, Pin1 upregulates the expression of cyclin D1. This, in turn, could facilitate the transition from quiescence to the G1 phase (re-entry in cell cycle) in a neuron and, subsequently, neuronal dedifferentiation and apoptosis. The involvement of Pin1 in the G0/G1 transition in neurons points to its function as a good target for the development of new therapeutic strategies in neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12540053     DOI: 10.1385/JMN:19:3:275

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

1.  The Arabidopsis thaliana PIN1At gene encodes a single-domain phosphorylation-dependent peptidyl prolyl cis/trans isomerase.

Authors:  I Landrieu; L De Veylder; J S Fruchart; B Odaert; P Casteels; D Portetelle; M Van Montagu; D Inzé; G Lippens
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

2.  Structural basis for phosphoserine-proline recognition by group IV WW domains.

Authors:  M A Verdecia; M E Bowman; K P Lu; T Hunter; J P Noel
Journal:  Nat Struct Biol       Date:  2000-08

3.  Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.

Authors:  X Z Zhou; O Kops; A Werner; P J Lu; M Shen; G Stoller; G Küllertz; M Stark; G Fischer; K P Lu
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

4.  Function of WW domains as phosphoserine- or phosphothreonine-binding modules.

Authors:  P J Lu; X Z Zhou; M Shen; K P Lu
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

5.  A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease.

Authors:  G A Jicha; E Lane; I Vincent; L Otvos; R Hoffmann; P Davies
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

6.  Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent.

Authors:  R Ranganathan; K P Lu; T Hunter; J P Noel
Journal:  Cell       Date:  1997-06-13       Impact factor: 41.582

7.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

Authors:  G M Wulf; A Ryo; G G Wulf; S W Lee; T Niu; V Petkova; K P Lu
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

8.  Discovering high-affinity ligands for proteins.

Authors:  P J Hajduk; R P Meadows; S W Fesik
Journal:  Science       Date:  1997-10-17       Impact factor: 47.728

9.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.

Authors:  P J Lu; G Wulf; X Z Zhou; P Davies; K P Lu
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

10.  1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides.

Authors:  R Wintjens; J M Wieruszeski; H Drobecq; P Rousselot-Pailley; L Buée; G Lippens; I Landrieu
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

View more
  10 in total

1.  Unraveling a phosphorylation event in a folded protein by NMR spectroscopy: phosphorylation of the Pin1 WW domain by PKA.

Authors:  Caroline Smet-Nocca; Hélène Launay; Jean-Michel Wieruszeski; Guy Lippens; Isabelle Landrieu
Journal:  J Biomol NMR       Date:  2013-03-02       Impact factor: 2.835

2.  Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation.

Authors:  Angélique Deleersnijder; Anne-Sophie Van Rompuy; Linda Desender; Hans Pottel; Luc Buée; Zeger Debyser; Veerle Baekelandt; Melanie Gerard
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

3.  Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.

Authors:  Mark Yarchoan; Bryan D James; Raj C Shah; Zoe Arvanitakis; Robert S Wilson; Julie Schneider; David A Bennett; Steven E Arnold
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.

Authors:  Isabelle Landrieu; Elian Dupré; Davy Sinnaeve; Léa El Hajjar; Caroline Smet-Nocca
Journal:  Front Chem       Date:  2022-05-12       Impact factor: 5.545

5.  Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.

Authors:  Erin L Reineke; Minh Lam; Qing Liu; Yu Liu; Kristopher J Stanya; Kun-Sang Chang; Anthony R Means; Hung-Ying Kao
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

6.  A sequential metal-catalyzed C-N bond formation in the synthesis of 2-amido-indoles.

Authors:  Pei-Yuan Yao; Yu Zhang; Richard P Hsung; Kang Zhao
Journal:  Org Lett       Date:  2008-08-28       Impact factor: 6.005

7.  Targeting gonadotropins: an alternative option for Alzheimer disease treatment.

Authors:  Gemma Casadesus; Emma Ramiro Puig; Kate M Webber; Craig S Atwood; Margarida Castell Escuer; Richard L Bowen; George Perry; Mark A Smith
Journal:  J Biomed Biotechnol       Date:  2006

8.  The Effect of Neurotoxin MPTP and Neuroprotector Isatin on the Profile of Ubiquitinated Brain Mitochondrial Proteins.

Authors:  Olga Buneeva; Arthur Kopylov; Inga Kapitsa; Elena Ivanova; Victor Zgoda; Alexei Medvedev
Journal:  Cells       Date:  2018-07-31       Impact factor: 6.600

Review 9.  Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease.

Authors:  Marta Campora; Valeria Francesconi; Silvia Schenone; Bruno Tasso; Michele Tonelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-05

Review 10.  Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K/Akt Pathway Provide Clues?

Authors:  Rachel M Barker; Jeff M P Holly; Kalina M Biernacka; Shelley J Allen-Birt; Claire M Perks
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-23       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.